dr. pennell on considerations for immediate treatment in lung cancer
Published 4 years ago • 176 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
2:10
dr. pennell on unique treatment-related toxicities in lung cancer
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
2:12
dr. pennell on the evolution of targeted treatment in nsclc
-
1:22
dr. pennell on challenges with ngs in lung cancer
-
1:39
dr. pennell on benefits of liquid biopsies in lung cancer
-
1:41
dr. pennell on remaining challenges in nsclc
-
0:51
dr. pennell on the cost effectiveness of ngs in nsclc
-
51:55
the truth about palliative care in oncology with dr. janet abrahm
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
1:53
dr. pennell on the risks associated with sequential therapy with immunotherapy/tkis in lung cancer
-
1:34
dr. pennell on the use of brigatinib in alk nsclc
-
2:26
dr. pennell on the underutilization of genetic testing in lung cancer
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning
-
5:00
implications for pembrolizumab in nsclc
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer
-
2:17
nathan pennell, md, phd | cleveland clinic hematology & oncology
-
3:27
important long-term considerations in lung cancer
-
3:53
pennell liquid biopsies for egfr t790m nonsmall cell lung cancer nsclc
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment